OrthoPediatrics Corp. (KIDS) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

22/25

Growth 4 Margin 5 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

22
Orthopediatrics (KIDS) Q2 2026: Trauma & Deformity Jumps 26% as Multi-Year Innovation Cycle Gains Traction
August 05, 2026
22
KIDS Q1 2026: 22% International Surge Signals Global Pediatric Platform Leverage
May 01, 2026
22
OrthoPediatrics (KIDS) Q4 2025: Gross Margin Jumps to 73% as Product Super Cycle Accelerates
February 27, 2026
22
Orthopediatrics (KIDS) Q3 2025: 56% EBITDA Gain Anchors Margin-Focused Growth as 7D and LATAM Drag Linger
October 29, 2025
18
OrthoPediatrics (KIDS) Q2 2025: Scoliosis Revenue Jumps 35% as Clinic Expansion Outpaces Plan
August 06, 2025
23
OrthoPediatrics (KIDS) Q1 2025: Scoliosis Revenue Jumps 34% as Portfolio Expansion Accelerates Share Gains
July 04, 2025
OrthoPediatrics (KIDS) Q4 2024: 40% Revenue Growth Validates Market Leadership and OPSB Expansion
March 04, 2025

Browse all companies